HRP20070291T3 - Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis - Google Patents
Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosisInfo
- Publication number
- HRP20070291T3 HRP20070291T3 HR20070291T HRP20070291T HRP20070291T3 HR P20070291 T3 HRP20070291 T3 HR P20070291T3 HR 20070291 T HR20070291 T HR 20070291T HR P20070291 T HRP20070291 T HR P20070291T HR P20070291 T3 HRP20070291 T3 HR P20070291T3
- Authority
- HR
- Croatia
- Prior art keywords
- zinc
- treatment
- multiple sclerosis
- pharmaceutical composition
- hyaluronate complex
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940099552 hyaluronan Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0303779A HUP0303779A2 (en) | 2003-11-20 | 2003-11-20 | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
| PCT/HU2004/000107 WO2005049047A1 (en) | 2003-11-20 | 2004-11-18 | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20070291T3 true HRP20070291T3 (en) | 2007-10-31 |
Family
ID=90001707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20070291T HRP20070291T3 (en) | 2003-11-20 | 2007-07-03 | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070123488A1 (de) |
| EP (1) | EP1699468B1 (de) |
| JP (1) | JP4778908B2 (de) |
| CN (1) | CN1882352B (de) |
| AT (1) | ATE359800T1 (de) |
| CY (1) | CY1106617T1 (de) |
| DE (1) | DE602004006024T2 (de) |
| DK (1) | DK1699468T3 (de) |
| EA (1) | EA009209B1 (de) |
| ES (1) | ES2286698T3 (de) |
| HK (1) | HK1098352A1 (de) |
| HR (1) | HRP20070291T3 (de) |
| HU (1) | HUP0303779A2 (de) |
| NO (1) | NO336121B1 (de) |
| PL (1) | PL1699468T3 (de) |
| PT (1) | PT1699468E (de) |
| RS (2) | RS20060325A (de) |
| SI (1) | SI1699468T1 (de) |
| UA (1) | UA83516C2 (de) |
| WO (1) | WO2005049047A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070099867A1 (en) * | 2005-05-24 | 2007-05-03 | Glycoscience Laboratories, Inc. | Pharmaceutical agent containing hyaluronan as an active ingredient |
| JP2007153761A (ja) * | 2005-12-01 | 2007-06-21 | Toshitsu Kagaku Kenkyusho:Kk | シナプス伝達促進剤及びシナプス保護剤 |
| CA2560844C (en) * | 2005-09-26 | 2011-05-17 | Glycoscience Laboratories, Inc. | Pharmaceutical agent containing hyaluronan as an active ingredient |
| JP2009091248A (ja) * | 2006-01-17 | 2009-04-30 | Toshitsu Kagaku Kenkyusho:Kk | 外傷性神経障害および／または運動機能障害の治療薬 |
| US8153614B2 (en) | 2006-12-05 | 2012-04-10 | Glycoscience Laboratories, Inc. | Treatment of osteoarthritis |
| JP2007277258A (ja) * | 2007-06-20 | 2007-10-25 | Toshitsu Kagaku Kenkyusho:Kk | 炎症及び神経疾患の治療剤及び予防剤 |
| ES2612001T4 (es) * | 2009-08-20 | 2018-02-07 | Yeda Research & Development Company, Ltd. | Terapia de baja frecuencia con acetato de glatirámero |
| CN111647100B (zh) * | 2020-07-14 | 2022-03-01 | 山东华熙海御生物医药有限公司 | 一种高分子量透明质酸锌的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| US6013641A (en) * | 1995-09-28 | 2000-01-11 | Sangstat Medical Corporation | Use of hyaluronic acid as an immunosuppressant |
| HU225991B1 (en) * | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
| DE19721099C2 (de) * | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten |
| JP2003089647A (ja) * | 1999-03-10 | 2003-03-28 | Takada Seiyaku Kk | 関節性疾患治療剤 |
| JP2001163789A (ja) * | 1999-12-13 | 2001-06-19 | Maruho Co Ltd | マトリックスメタロプロテアーゼ阻害用医薬組成物 |
| BG104880A (en) * | 2000-10-24 | 2002-04-30 | Иван ХРИСТОВ | Medicamentous preparation for multiple sclerosis treatment |
| WO2002074318A1 (fr) * | 2001-03-15 | 2002-09-26 | Seikagaku Corporation | Agents de regulation d'expression d'il-12 |
-
2003
- 2003-11-20 HU HU0303779A patent/HUP0303779A2/hu unknown
-
2004
- 2004-11-18 EP EP04798745A patent/EP1699468B1/de active Active
- 2004-11-18 RS YUP-2006/0325A patent/RS20060325A/sr unknown
- 2004-11-18 PT PT04798745T patent/PT1699468E/pt unknown
- 2004-11-18 PL PL04798745T patent/PL1699468T3/pl unknown
- 2004-11-18 CN CN200480034039XA patent/CN1882352B/zh not_active Expired - Fee Related
- 2004-11-18 ES ES04798745T patent/ES2286698T3/es active Active
- 2004-11-18 UA UAA200606730A patent/UA83516C2/uk unknown
- 2004-11-18 WO PCT/HU2004/000107 patent/WO2005049047A1/en active Application Filing
- 2004-11-18 DE DE602004006024T patent/DE602004006024T2/de active Active
- 2004-11-18 AT AT04798745T patent/ATE359800T1/de active
- 2004-11-18 US US10/579,256 patent/US20070123488A1/en not_active Abandoned
- 2004-11-18 SI SI200430325T patent/SI1699468T1/sl unknown
- 2004-11-18 DK DK04798745T patent/DK1699468T3/da active
- 2004-11-18 JP JP2006540634A patent/JP4778908B2/ja not_active Expired - Fee Related
- 2004-11-18 EA EA200600998A patent/EA009209B1/ru not_active IP Right Cessation
- 2004-11-18 RS RSP-2007/0270A patent/RS50523B/sr unknown
-
2006
- 2006-06-19 NO NO20062857A patent/NO336121B1/no not_active IP Right Cessation
-
2007
- 2007-05-04 HK HK07104747.1A patent/HK1098352A1/xx not_active IP Right Cessation
- 2007-05-23 CY CY20071100698T patent/CY1106617T1/el unknown
- 2007-07-03 HR HR20070291T patent/HRP20070291T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0303779A2 (en) | 2006-02-28 |
| WO2005049047A1 (en) | 2005-06-02 |
| DE602004006024T2 (de) | 2007-12-27 |
| NO336121B1 (no) | 2015-05-18 |
| EP1699468B1 (de) | 2007-04-18 |
| CN1882352B (zh) | 2010-08-04 |
| RS20060325A (en) | 2008-08-07 |
| CN1882352A (zh) | 2006-12-20 |
| HUP0303779D0 (en) | 2004-03-01 |
| DK1699468T3 (da) | 2007-09-03 |
| EA200600998A1 (ru) | 2006-10-27 |
| PL1699468T3 (pl) | 2007-09-28 |
| ES2286698T3 (es) | 2007-12-01 |
| NO20062857L (no) | 2006-08-18 |
| US20070123488A1 (en) | 2007-05-31 |
| SI1699468T1 (sl) | 2007-08-31 |
| RS50523B (sr) | 2010-05-07 |
| UA83516C2 (uk) | 2008-07-25 |
| HK1098352A1 (en) | 2007-07-20 |
| DE602004006024D1 (de) | 2007-05-31 |
| EA009209B1 (ru) | 2007-12-28 |
| ATE359800T1 (de) | 2007-05-15 |
| JP4778908B2 (ja) | 2011-09-21 |
| CY1106617T1 (el) | 2012-01-25 |
| JP2007512311A (ja) | 2007-05-17 |
| PT1699468E (pt) | 2007-06-05 |
| EP1699468A1 (de) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
| IL174154A (en) | History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines | |
| TW200612910A (en) | Medicaments comprising carbonyl compounds, and the use thereof | |
| RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| SE0302811D0 (sv) | Novel compounds | |
| TW200635923A (en) | Tricyclic heterocycles, their manufacture and use as pharmaceutical agents | |
| TW200505875A (en) | Novel compounds | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| PT1506185E (pt) | Compostos novos e sua utilizacao | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| DE60327693D1 (de) | Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff | |
| NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
| CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| HRPK20030734B3 (en) | A combination comprising combretastatin and anticancer agents | |
| RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
| GEP20094801B (en) | Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof | |
| DK1643999T3 (da) | Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| PT1713438E (pt) | Sabonete medicinal | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine |